David J. Clark
2017 - Aldeyra Therapeutics
In 2017, David J. Clark earned a total compensation of $1.1M as Chief Medical Officer at Aldeyra Therapeutics, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $133,525 |
|---|---|
| Option Awards | $594,999 |
| Salary | $376,250 |
| Total | $1,104,774 |
Clark received $595K in option awards, accounting for 54% of the total pay in 2017.
Clark also received $133.5K in non-equity incentive plan and $376.3K in salary.
Rankings
In 2017, David J. Clark's compensation ranked 8,516th out of 14,666 executives tracked by ExecPay. In other words, Clark earned more than 41.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,516 out of 14,666 | 42nd |
Division Manufacturing | 3,231 out of 5,772 | 44th |
Major group Chemicals And Allied Products | 1,075 out of 2,075 | 48th |
Industry group Drugs | 850 out of 1,731 | 51st |
Industry Pharmaceutical Preparations | 663 out of 1,333 | 50th |
Source: SEC filing on April 25, 2018.
Clark's colleagues
We found two more compensation records of executives who worked with David J. Clark at Aldeyra Therapeutics in 2017.